Evidence map›Paper›PMID 29872913›Full record

ArticleEuropean radiology2018

Wall enhancement of intracranial unruptured aneurysm is associated with increased rupture risk and traditional risk factors.

Chengcheng Zhu, Xinrui Wang, Andrew J Degnan, Zhang Shi, Bing Tian, Qi Liu, Christopher Hess, David Saloner, Jianping Lu

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Vessel Wall Imaging of Cerebrovascular Disorders.Current treatment options in cardiovascular medicine · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Chengcheng ZhuDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, CA, USA.
Xinrui WangDepartment of Radiology, Changhai Hospital, Shanghai, China.
Andrew J DegnanDepartment of Radiology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Zhang ShiDepartment of Radiology, Changhai Hospital, Shanghai, China.
Bing TianDepartment of Radiology, Changhai Hospital, Shanghai, China.
Qi LiuDepartment of Radiology, Changhai Hospital, Shanghai, China.
Christopher HessDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, CA, USA.
David SalonerDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, CA, USA.
Jianping LuDepartment of Radiology, Changhai Hospital, Shanghai, China. cjr.lujianping@vip.163.com.ORCID http://orcid.org/0000-0002-0380-7470
Second Military Medical University · CNChildren's Hospital of Philadelphia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAneurysm wall enhancement (AWE) on MRI has been considered an imaging marker to indicate active aneurysm inflammation, but no prospective studies have assessed the ability of AWE to predict rupture risk or growth. We aim to study the association of AWE with traditional risk factors and the estimated rupture risk.

methodsSeventy-seven patients (mean age, 58.4 ± 10.8 years; 57% female) with 88 asymptomatic intracranial saccular aneurysms underwent both 3-T high-resolution MRI and three-dimensional (3D) rotational digital subtraction angiography (DSA). Geometric and morphologic parameters were measured on DSA, and the degree of AWE on MRI was graded. One- and 5-year rupture risks of aneurysms were estimated using the UCAS and PHASES calculator. Parameters associated with AWE were analyzed using uni- and multivariate logistic regression.

resultsNon-internal carotid artery location (OR 3.4, 95% CI 1.6-7.1) and aneurysm size (OR 1.9, 95% CI 1.3-2.7) were independently associated with AWE (p < 0.05). Aneurysms with AWE had significantly higher estimated rupture risk (1 and 5 year, 1.9% and 5.8%) than aneurysms without AWE (0.5% and 2.1%) (p < 0.001). Stronger and larger areas of AWE were correlated with the aneurysm size, size ratio and estimated rupture risk (R

conclusionsProspective assessment of asymptomatic intracranial aneurysms with MRI suggests that AWE is associated with traditional risk factors and estimated short- and medium-term rupture risk. KEY POINTS: • AWE independently associates with aneurysm location and size. • Aneurysms with AWE have higher rupture risk than aneurysms without AWE. • Stronger and larger areas of AWE correlated with the aneurysm size, size ratio and rupture risk.

Indexed as

Aneurysm, RupturedAngiography, Digital SubtractionFemaleHumansImaging, Three-DimensionalIntracranial AneurysmMagnetic Resonance ImagingMaleMiddle AgedProspective StudiesRisk AssessmentRisk FactorsDigital subtraction angiographyGadoliniumIntracranial aneurysmMagnetic resonance imagingRisk factor

Identifiers

PMID29872913
OpenAlexW2806267796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.